speb/financial-data huggingface dataset:
ICG balance_sheet (annual, 2023-12-31) — Raw Materials: 20686000.00
ICG balance_sheet (annual, 2023-12-31) — Receivables: 13833000.00
ICG income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 73147000.00
ICG income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3830000.00
ICG cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
ICG income_statement (annual, 2023-12-31) — Research And Development: 42304000.00
ICG balance_sheet (annual, 2023-12-31) — Retained Earnings: 713960000.00
ICG cash_flow (annual, 2023-12-31) — Sale Of Investment: 639000.00
ICG cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
ICG income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 6532000.00
ICG income_statement (annual, 2023-12-31) — Selling General And Administration: 31742000.00
ICG balance_sheet (annual, 2023-12-31) — Share Issued: 119876032.00
ICG cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
ICG cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
ICG income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
ICG cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3474000.00
ICG balance_sheet (annual, 2023-12-31) — Stockholders Equity: 950325000.00
ICG balance_sheet (annual, 2023-12-31) — Tangible Book Value: 946255000.00
ICG income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -86240.00
ICG income_statement (annual, 2023-12-31) — Tax Provision: -8756000.00
ICG income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
ICG balance_sheet (annual, 2023-12-31) — Taxes Receivable: 3989000.00
ICG balance_sheet (annual, 2023-12-31) — Total Assets: 979250000.00
ICG balance_sheet (annual, 2023-12-31) — Total Capitalization: 950325000.00
ICG balance_sheet (annual, 2023-12-31) — Total Debt: 1864000.00
ICG balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 950325000.00
ICG income_statement (annual, 2023-12-31) — Total Expenses: 133992000.00
ICG balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 28925000.00
ICG balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 201734000.00
ICG balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 761000.00
ICG income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -64968000.00
ICG balance_sheet (annual, 2023-12-31) — Total Tax Payable: 4855000.00
ICG income_statement (annual, 2023-12-31) — Total Unusual Items: -350000.00
ICG income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -350000.00
ICG balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ICG cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -174000.00
ICG balance_sheet (annual, 2023-12-31) — Work In Process: 9756000.00
ICG balance_sheet (annual, 2023-12-31) — Working Capital: 749352000.00
ICG balance_sheet (quarterly, 2024-09-30) — Accrued Interest Receivable: 5389000.00
ICG balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -9665000.00
ICG balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 43673000.00
ICG balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 113677000.00
ICG balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 13269000.00
ICG balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1136000.00
ICG balance_sheet (quarterly, 2024-09-30) — Finished Goods: 1199000.00
ICG balance_sheet (quarterly, 2024-09-30) — Inventories Adjustments Allowances: -63456000.00
ICG balance_sheet (quarterly, 2024-09-30) — Leases: 147000.00
ICG balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 14570000.00
ICG balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 543000.00
ICG balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 543000.00
ICG balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 0.00
ICG balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2937000.00
ICG balance_sheet (quarterly, 2024-09-30) — Other Payable: 8631000.00
ICG balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 51165000.00
ICG balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
ICG balance_sheet (quarterly, 2024-09-30) — Raw Materials: 31406000.00
ICG balance_sheet (quarterly, 2024-09-30) — Receivables: 26908000.00
ICG balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 21519000.00
ICG balance_sheet (quarterly, 2024-09-30) — Work In Process: 118287000.00
ICG income_statement (annual, 2024-12-31) — +Operating Expense: 140268000.00
ICG income_statement (quarterly, 2024-12-31) — +Operating Expense: 48130000.00
ICG income_statement (annual, 2024-12-31) — +Total Revenue: 281767000.00
ICG income_statement (quarterly, 2024-12-31) — +Total Revenue: 74177000.00
ICG balance_sheet (annual, 2024-12-31) — Accounts Payable: 14847000.00
ICG balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 14847000.00
ICG balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 1346000.00
ICG balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 1346000.00
ICG balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -11014000.00
ICG balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -11014000.00
ICG balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 195236000.00
ICG balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 195236000.00
ICG cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 476000.00
ICG cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 476000.00
ICG cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 4614000.00
ICG cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -1445000.00
ICG income_statement (annual, 2024-12-31) — Basic Average Shares: 59966026.00
ICG income_statement (quarterly, 2024-12-31) — Basic Average Shares: 59981481.00
ICG income_statement (annual, 2024-12-31) — Basic EPS: 0.86
ICG income_statement (quarterly, 2024-12-31) — Basic EPS: 0.22
ICG cash_flow (annual, 2024-12-31) — Beginning Cash Position: 585171000.00
ICG cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 514027000.00
ICG balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 43116000.00
ICG balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 43116000.00
ICG cash_flow (annual, 2024-12-31) — Capital Expenditure: -10077000.00
ICG cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -5285000.00
ICG balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 272000.00
ICG balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 272000.00
ICG balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
ICG balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1000.00
ICG balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 322252000.00
ICG balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 322252000.00
ICG balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 520814000.00
ICG balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 520814000.00
ICG balance_sheet (annual, 2024-12-31) — Cash Equivalents: 8648000.00
ICG balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 8648000.00
ICG balance_sheet (annual, 2024-12-31) — Cash Financial: 313604000.00
ICG balance_sheet (quarterly, 2024-12-31) — Cash Financial: 313604000.00
ICG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
ICG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -125936000.00
ICG cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -61937000.00
ICG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -138253000.00
ICG cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -20220000.00
ICG cash_flow (annual, 2024-12-31) — Change In Account Payable: 14652000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Account Payable: 7202000.00
ICG cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 5542000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 6625000.00
ICG cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 389000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: -1358000.00
ICG cash_flow (annual, 2024-12-31) — Change In Inventory: -97513000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Inventory: -11601000.00
ICG cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 421000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 432000.00
ICG cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 16694000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -3766000.00
ICG cash_flow (annual, 2024-12-31) — Change In Payable: 15041000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Payable: 5844000.00
ICG cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 20583000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 12469000.00
ICG cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -25626000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 11232000.00
ICG cash_flow (annual, 2024-12-31) — Change In Tax Payable: 389000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: -1358000.00
ICG cash_flow (annual, 2024-12-31) — Change In Working Capital: -85441000.00
ICG cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 8766000.00
ICG cash_flow (annual, 2024-12-31) — Changes In Cash: -264189000.00
ICG cash_flow (quarterly, 2024-12-31) — Changes In Cash: -84421000.00
ICG balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
ICG balance_sheet (quarterly, 2024-12-31) — Common Stock: 1000.00
ICG balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1013067000.00
ICG balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1013067000.00
ICG cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
ICG balance_sheet (annual, 2024-12-31) — Construction In Progress: 107942000.00
ICG balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 107942000.00
ICG income_statement (annual, 2024-12-31) — Cost Of Revenue: 130452000.00
ICG income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 54752000.00
ICG balance_sheet (annual, 2024-12-31) — Current Assets: 720900000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Assets: 720900000.00
ICG balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 272000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 272000.00
ICG balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 272000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 272000.00
ICG balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 37447000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 37447000.00
ICG balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 37447000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 37447000.00
ICG balance_sheet (annual, 2024-12-31) — Current Liabilities: 76442000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 76442000.00
ICG balance_sheet (annual, 2024-12-31) — Current Provisions: 562000.00
ICG balance_sheet (quarterly, 2024-12-31) — Current Provisions: 562000.00
ICG cash_flow (annual, 2024-12-31) — Deferred Income Tax: -16043000.00
ICG cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: -10159000.00
ICG cash_flow (annual, 2024-12-31) — Deferred Tax: -16043000.00
ICG cash_flow (quarterly, 2024-12-31) — Deferred Tax: -10159000.00
ICG cash_flow (annual, 2024-12-31) — Depreciation: 4507000.00
ICG cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4983000.00
ICG cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 1272000.00
ICG cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 4983000.00
ICG cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 1272000.00
ICG income_statement (annual, 2024-12-31) — Diluted Average Shares: 60005903.00
ICG income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 59990448.00
ICG income_statement (annual, 2024-12-31) — Diluted EPS: 0.86
ICG income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.22
ICG income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 12781000.00
ICG income_statement (annual, 2024-12-31) — EBIT: 50233000.00
ICG income_statement (quarterly, 2024-12-31) — EBIT: 10481000.00
ICG income_statement (annual, 2024-12-31) — EBITDA: 55216000.00
ICG income_statement (quarterly, 2024-12-31) — EBITDA: 11753000.00
ICG cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 1270000.00
ICG cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 2225000.00
ICG cash_flow (annual, 2024-12-31) — End Cash Position: 322252000.00
ICG cash_flow (quarterly, 2024-12-31) — End Cash Position: 322252000.00
ICG cash_flow (annual, 2024-12-31) — Financing Cash Flow: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 0.00
ICG balance_sheet (annual, 2024-12-31) — Finished Goods: 2346000.00
ICG balance_sheet (quarterly, 2024-12-31) — Finished Goods: 2346000.00
ICG cash_flow (annual, 2024-12-31) — Free Cash Flow: -148330000.00
ICG cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -27769000.00
ICG cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1901000.00
ICG cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -1689000.00
ICG cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ICG income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 23384000.00
ICG income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 32172000.00
ICG balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 55539000.00
ICG balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 55539000.00
ICG income_statement (annual, 2024-12-31) — General And Administrative Expense: 30248000.00
ICG income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 7237000.00
ICG balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 152342000.00
ICG balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 152342000.00
ICG balance_sheet (annual, 2024-12-31) — Gross PPE: 168351000.00
ICG balance_sheet (quarterly, 2024-12-31) — Gross PPE: 168351000.00
ICG income_statement (annual, 2024-12-31) — Gross Profit: 151315000.00
ICG income_statement (quarterly, 2024-12-31) — Gross Profit: 19425000.00
ICG income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 210000.00
ICG cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 15422000.00
ICG cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 3735000.00
ICG balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2023000.00
ICG balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 2023000.00
ICG income_statement (annual, 2024-12-31) — Interest Expense: 56000.00
ICG income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 56000.00
ICG income_statement (annual, 2024-12-31) — Interest Income: 16235000.00
ICG income_statement (quarterly, 2024-12-31) — Interest Income: 3778000.00
ICG income_statement (annual, 2024-12-31) — Interest Income Non Operating: 16235000.00
ICG income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 3778000.00
ICG balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -61247000.00
ICG balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -61247000.00
ICG balance_sheet (annual, 2024-12-31) — Inventory: 98614000.00
ICG balance_sheet (quarterly, 2024-12-31) — Inventory: 98614000.00
ICG balance_sheet (annual, 2024-12-31) — Invested Capital: 1013067000.00
ICG balance_sheet (quarterly, 2024-12-31) — Invested Capital: 1013067000.00
ICG cash_flow (annual, 2024-12-31) — Investing Cash Flow: -125936000.00
ICG cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -61937000.00
ICG balance_sheet (annual, 2024-12-31) — Investments And Advances: 20569000.00
ICG balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 20569000.00
ICG cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ICG balance_sheet (annual, 2024-12-31) — Leases: 148000.00
ICG balance_sheet (quarterly, 2024-12-31) — Leases: 148000.00
ICG balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
ICG balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
ICG balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 16873000.00
ICG balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 16873000.00
ICG cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
ICG cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
ICG cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -1382000.00
ICG cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -215000.00
ICG income_statement (annual, 2024-12-31) — Net Income: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income: 12781000.00
ICG income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 12781000.00
ICG income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 12781000.00
ICG income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 12781000.00
ICG income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 12781000.00
ICG cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 51497000.00
ICG cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 12781000.00
ICG income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 51497000.00
ICG income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 12781000.00
ICG cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
ICG income_statement (annual, 2024-12-31) — Net Interest Income: 16179000.00
ICG income_statement (quarterly, 2024-12-31) — Net Interest Income: 3722000.00
ICG cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -93512000.00
ICG cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -58576000.00
ICG income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 16179000.00
ICG income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 3722000.00
ICG cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -22347000.00
ICG cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 1924000.00
ICG balance_sheet (annual, 2024-12-31) — Net PPE: 157337000.00
ICG balance_sheet (quarterly, 2024-12-31) — Net PPE: 157337000.00
ICG cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -10077000.00
ICG cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -5285000.00
ICG balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 860725000.00
ICG balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 860725000.00
ICG balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 28942000.00
ICG balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 28942000.00
ICG balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 28942000.00
ICG balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 28942000.00
ICG balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 0.00
ICG balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 0.00
ICG income_statement (annual, 2024-12-31) — Normalized EBITDA: 32042000.00
ICG income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -20209000.00
ICG income_statement (annual, 2024-12-31) — Normalized Income: 34116500.00
ICG income_statement (quarterly, 2024-12-31) — Normalized Income: -11190500.00
ICG cash_flow (annual, 2024-12-31) — Operating Cash Flow: -138253000.00
ICG cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -22484000.00
ICG cash_flow (annual, 2024-12-31) — Operating Gains Losses: -3283000.00
ICG cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -1904000.00
ICG income_statement (annual, 2024-12-31) — Operating Income: 11047000.00
ICG income_statement (quarterly, 2024-12-31) — Operating Income: -28705000.00
ICG income_statement (annual, 2024-12-31) — Operating Revenue: 281767000.00
ICG income_statement (quarterly, 2024-12-31) — Operating Revenue: 74177000.00
ICG balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 120020962.00
ICG balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 120020962.00
ICG balance_sheet (annual, 2024-12-31) — Other Current Assets: 32010000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 32010000.00
ICG balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3851000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 3851000.00
ICG balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 55539000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 55539000.00
ICG balance_sheet (annual, 2024-12-31) — Other Equity Interest: -1000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: -1000.00
ICG income_statement (annual, 2024-12-31) — Other Gand A: 30248000.00
ICG income_statement (quarterly, 2024-12-31) — Other Gand A: 7237000.00
ICG income_statement (annual, 2024-12-31) — Other Income Expense: 22951000.00
ICG income_statement (quarterly, 2024-12-31) — Other Income Expense: 28894000.00
ICG balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 152342000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 152342000.00
ICG cash_flow (annual, 2024-12-31) — Other Non Cash Items: -142991000.00
ICG cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -33536000.00
ICG balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 9419000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 9419000.00
ICG income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -223000.00
ICG income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -3068000.00
ICG income_statement (annual, 2024-12-31) — Other Operating Expenses: -7891000.00
ICG balance_sheet (annual, 2024-12-31) — Other Payable: 12798000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Payable: 12798000.00
ICG balance_sheet (annual, 2024-12-31) — Other Properties: 272000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Properties: 272000.00
ICG balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 198562000.00
ICG balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 198562000.00
ICG balance_sheet (annual, 2024-12-31) — Payables: 34310000.00
ICG balance_sheet (quarterly, 2024-12-31) — Payables: 34310000.00
ICG balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 34310000.00
ICG balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 34310000.00
ICG balance_sheet (annual, 2024-12-31) — Prepaid Assets: 41105000.00
ICG balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 41105000.00
ICG income_statement (annual, 2024-12-31) — Pretax Income: 50177000.00
ICG income_statement (quarterly, 2024-12-31) — Pretax Income: 3911000.00
ICG balance_sheet (annual, 2024-12-31) — Properties: 0.00
ICG balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ICG cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 39377000.00
ICG cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: -916000.00
ICG cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
ICG cash_flow (annual, 2024-12-31) — Purchase Of Investment: -494836000.00
ICG cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -425102000.00
ICG cash_flow (annual, 2024-12-31) — Purchase Of PPE: -10077000.00
ICG cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -5285000.00
ICG balance_sheet (annual, 2024-12-31) — Raw Materials: 29834000.00
ICG balance_sheet (quarterly, 2024-12-31) — Raw Materials: 29834000.00
ICG balance_sheet (annual, 2024-12-31) — Receivables: 28357000.00
ICG balance_sheet (quarterly, 2024-12-31) — Receivables: 28357000.00
ICG income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 130452000.00
ICG income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 54752000.00
ICG income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4983000.00
ICG income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 1272000.00
ICG income_statement (annual, 2024-12-31) — Research And Development: 109443000.00
ICG income_statement (quarterly, 2024-12-31) — Research And Development: 45887000.00
ICG balance_sheet (annual, 2024-12-31) — Retained Earnings: 762292000.00
ICG balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 762292000.00
ICG cash_flow (annual, 2024-12-31) — Sale Of Investment: 401324000.00
ICG cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 366526000.00
ICG cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
ICG income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 8468000.00
ICG income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 2897000.00
ICG income_statement (annual, 2024-12-31) — Selling General And Administration: 38716000.00
ICG income_statement (quarterly, 2024-12-31) — Selling General And Administration: 10134000.00
ICG balance_sheet (annual, 2024-12-31) — Share Issued: 120081456.00
ICG balance_sheet (quarterly, 2024-12-31) — Share Issued: 120081456.00
ICG income_statement (annual, 2024-12-31) — Special Income Charges: -210000.00
ICG cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8974000.00
ICG cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 1993000.00
ICG balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1013067000.00
ICG balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1013067000.00
ICG balance_sheet (annual, 2024-12-31) — Tangible Book Value: 860725000.00
ICG balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 860725000.00
ICG income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 5793500.00
ICG income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 7990500.00
ICG income_statement (annual, 2024-12-31) — Tax Provision: -1320000.00
ICG income_statement (quarterly, 2024-12-31) — Tax Provision: -8870000.00
ICG income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
ICG income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
ICG balance_sheet (annual, 2024-12-31) — Taxes Receivable: 27011000.00
ICG balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 27011000.00
ICG balance_sheet (annual, 2024-12-31) — Total Assets: 1089509000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Assets: 1089509000.00
ICG balance_sheet (annual, 2024-12-31) — Total Capitalization: 1013067000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 1013067000.00
ICG balance_sheet (annual, 2024-12-31) — Total Debt: 272000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Debt: 272000.00
ICG balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1013067000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1013067000.00
ICG income_statement (annual, 2024-12-31) — Total Expenses: 270720000.00
ICG income_statement (quarterly, 2024-12-31) — Total Expenses: 102882000.00
ICG balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 76442000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 76442000.00
ICG balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 368609000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 368609000.00
ICG balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICG income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 2946000.00
ICG income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -28900000.00
ICG balance_sheet (annual, 2024-12-31) — Total Tax Payable: 6665000.00
ICG balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 6665000.00
ICG income_statement (annual, 2024-12-31) — Total Unusual Items: 23174000.00
ICG income_statement (quarterly, 2024-12-31) — Total Unusual Items: 31962000.00
ICG income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 23174000.00
ICG income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 31962000.00
ICG balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 60494.00
ICG balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 60494.00
ICG cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 60000.00
ICG cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 664000.00
ICG balance_sheet (annual, 2024-12-31) — Work In Process: 127681000.00
ICG balance_sheet (quarterly, 2024-12-31) — Work In Process: 127681000.00
ICG balance_sheet (annual, 2024-12-31) — Working Capital: 644458000.00
ICG balance_sheet (quarterly, 2024-12-31) — Working Capital: 644458000.00
ICG income_statement (quarterly, 2025-03-31) — +Operating Expense: 38429000.00
ICG income_statement (quarterly, 2025-03-31) — +Total Revenue: 132391000.00
ICG balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5191000.00
ICG balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 201629000.00
ICG income_statement (quarterly, 2025-03-31) — Basic Average Shares: 60026526.00
ICG income_statement (quarterly, 2025-03-31) — Basic EPS: -0.56
ICG balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 0.00
ICG balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
ICG balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 243316000.00
ICG balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 543846000.00
ICG balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
ICG balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 985145000.00
ICG income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 57045000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 17367000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Assets: 719329000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 28866000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 28866000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 52906000.00
ICG balance_sheet (quarterly, 2025-03-31) — Current Provisions: 241000.00
ICG income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 60026526.00
ICG income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.56
ICG income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — EBIT: 36917000.00
ICG income_statement (quarterly, 2025-03-31) — EBITDA: 36917000.00
ICG income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -70993000.00
ICG balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 55371000.00
ICG income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 9838000.00
ICG balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 104990000.00
ICG balance_sheet (quarterly, 2025-03-31) — Gross PPE: 155934000.00
ICG income_statement (quarterly, 2025-03-31) — Gross Profit: 75346000.00
ICG balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 1241000.00
ICG income_statement (quarterly, 2025-03-31) — Interest Income: 3154000.00
ICG income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3154000.00
ICG balance_sheet (quarterly, 2025-03-31) — Inventory: 92494000.00
ICG balance_sheet (quarterly, 2025-03-31) — Invested Capital: 985145000.00
ICG balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 21913000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -33997000.00
ICG income_statement (quarterly, 2025-03-31) — Net Interest Income: 3154000.00
ICG income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3154000.00
ICG balance_sheet (quarterly, 2025-03-31) — Net PPE: 155934000.00
ICG balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 880155000.00
ICG balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 26173000.00
ICG balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 26173000.00
ICG income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 107910000.00
ICG income_statement (quarterly, 2025-03-31) — Normalized Income: 19247750.00
ICG income_statement (quarterly, 2025-03-31) — Operating Income: 36917000.00
ICG income_statement (quarterly, 2025-03-31) — Operating Revenue: 132391000.00
ICG balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 120742984.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 82989000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 55371000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -1000.00
ICG income_statement (quarterly, 2025-03-31) — Other Gand A: 9838000.00
ICG income_statement (quarterly, 2025-03-31) — Other Income Expense: -70800000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 104990000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 9712000.00
ICG income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 193000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Properties: 155934000.00
ICG balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 300530000.00
ICG balance_sheet (quarterly, 2025-03-31) — Payables: 6432000.00
ICG balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 23799000.00
ICG income_statement (quarterly, 2025-03-31) — Pretax Income: -30729000.00
ICG income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 57045000.00
ICG income_statement (quarterly, 2025-03-31) — Research And Development: 26354000.00
ICG balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 728145000.00
ICG income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2237000.00
ICG income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12075000.00
ICG balance_sheet (quarterly, 2025-03-31) — Share Issued: 120803478.00
ICG balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 985145000.00
ICG balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 880155000.00
ICG income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -17748250.00
ICG income_statement (quarterly, 2025-03-31) — Tax Provision: 3268000.00
ICG income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
ICG balance_sheet (quarterly, 2025-03-31) — Total Assets: 1038051000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 985145000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Debt: 0.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 985145000.00
ICG income_statement (quarterly, 2025-03-31) — Total Expenses: 95474000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 52906000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 318722000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICG income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 36917000.00
ICG balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1241000.00
ICG income_statement (quarterly, 2025-03-31) — Total Unusual Items: -70993000.00
ICG income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -70993000.00
ICG balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 60494.00
ICG balance_sheet (quarterly, 2025-03-31) — Working Capital: 666423000.00
ICG income_statement (quarterly, 2025-06-30) — +Operating Expense: 26447000.00
ICG income_statement (quarterly, 2025-06-30) — +Total Revenue: 43197000.00
ICG balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4304000.00
ICG balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 205460000.00
ICG income_statement (quarterly, 2025-06-30) — Basic Average Shares: 60451216.00
ICG income_statement (quarterly, 2025-06-30) — Basic EPS: 0.64
ICG balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 0.00
ICG balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
ICG balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 276280000.00
ICG balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 491729000.00
ICG balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
ICG balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1026689000.00
ICG income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 32907000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 12314000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Assets: 677111000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 15800000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 15800000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 32922000.00
ICG balance_sheet (quarterly, 2025-06-30) — Current Provisions: 94000.00
ICG income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 60501636.00
ICG income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.64
ICG income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — EBIT: -16157000.00
ICG income_statement (quarterly, 2025-06-30) — EBITDA: -16157000.00
ICG income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 42485000.00
ICG balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 54865000.00
ICG income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9179000.00
ICG balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 161023000.00
ICG balance_sheet (quarterly, 2025-06-30) — Gross PPE: 154929000.00
ICG income_statement (quarterly, 2025-06-30) — Gross Profit: 10290000.00
ICG balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 410000.00
ICG income_statement (quarterly, 2025-06-30) — Interest Income: 3080000.00
ICG income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3080000.00
ICG balance_sheet (quarterly, 2025-06-30) — Inventory: 131824000.00
ICG balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1026689000.00
ICG balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 22034000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 38252000.00
ICG income_statement (quarterly, 2025-06-30) — Net Interest Income: 3080000.00
ICG income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 3080000.00
ICG balance_sheet (quarterly, 2025-06-30) — Net PPE: 154929000.00
ICG balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 865666000.00
ICG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 34801000.00
ICG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 34801000.00
ICG income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -58642000.00
ICG income_statement (quarterly, 2025-06-30) — Normalized Income: 6388250.00
ICG income_statement (quarterly, 2025-06-30) — Operating Income: -16157000.00
ICG income_statement (quarterly, 2025-06-30) — Operating Revenue: 43197000.00
ICG balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 121173854.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 53558000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 54865000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -1000.00
ICG income_statement (quarterly, 2025-06-30) — Other Gand A: 9179000.00
ICG income_statement (quarterly, 2025-06-30) — Other Income Expense: 42660000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 161023000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 9713000.00
ICG income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 175000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Properties: 154929000.00
ICG balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 215449000.00
ICG balance_sheet (quarterly, 2025-06-30) — Payables: 4714000.00
ICG balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 17028000.00
ICG income_statement (quarterly, 2025-06-30) — Pretax Income: 29583000.00
ICG income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 32907000.00
ICG income_statement (quarterly, 2025-06-30) — Research And Development: 15238000.00
ICG balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 766364000.00
ICG income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2030000.00
ICG income_statement (quarterly, 2025-06-30) — Selling General And Administration: 11209000.00
ICG balance_sheet (quarterly, 2025-06-30) — Share Issued: 121234348.00
ICG balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1026689000.00
ICG balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 865666000.00
ICG income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 10621250.00
ICG income_statement (quarterly, 2025-06-30) — Tax Provision: -8669000.00
ICG income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
ICG balance_sheet (quarterly, 2025-06-30) — Total Assets: 1059611000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1026689000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Debt: 0.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1026689000.00
ICG income_statement (quarterly, 2025-06-30) — Total Expenses: 59354000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 32922000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 382500000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ICG income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -16157000.00
ICG balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 410000.00
ICG income_statement (quarterly, 2025-06-30) — Total Unusual Items: 42485000.00
ICG income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 42485000.00
ICG balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 60494.00
ICG balance_sheet (quarterly, 2025-06-30) — Working Capital: 644189000.00
ICG income_statement (quarterly, 2025-09-30) — +Operating Expense: 32701000.00
ICG income_statement (quarterly, 2025-09-30) — +Total Revenue: 9145000.00
ICG balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5428000.00
ICG balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 209053000.00
ICG income_statement (quarterly, 2025-09-30) — Basic Average Shares: 60626656.00
ICG income_statement (quarterly, 2025-09-30) — Basic EPS: 1.22
ICG balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
ICG balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
ICG balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 259483000.00
ICG balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 452684000.00
ICG balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
ICG balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1102832000.00
ICG income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 18220000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 14531000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Assets: 663463000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 0.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 20054000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 20054000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 40135000.00
ICG balance_sheet (quarterly, 2025-09-30) — Current Provisions: 122000.00
ICG income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 60890920.00
ICG income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.22
ICG income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — EBIT: -41776000.00
ICG income_statement (quarterly, 2025-09-30) — EBITDA: -41776000.00
ICG income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 105816000.00
ICG balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 52964000.00
ICG income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 7615000.00
ICG balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 266713000.00
ICG balance_sheet (quarterly, 2025-09-30) — Gross PPE: 142692000.00
ICG income_statement (quarterly, 2025-09-30) — Gross Profit: -9075000.00
ICG balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
ICG income_statement (quarterly, 2025-09-30) — Interest Income: 2368000.00
ICG income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2368000.00
ICG balance_sheet (quarterly, 2025-09-30) — Inventory: 130094000.00
ICG balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1102832000.00
ICG balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 21647000.00
ICG income_statement (quarterly, 2025-09-30) — Net Income: 74432000.00